MTOR and Alzheimer disease: TREM2/DAP12-mediated signals activate mammalian target of rapamycin (mTOR) to support microglial biosynthetic metabolism; Trem2 deficiency impairs cellular metabolism and promotes increased autophagy in microglia in an AD mouse model (Ulland et al., 2017).